Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Flow Cytometry (FACS) Antibodies

Anti-Human CD47/MER6 Antibody (5F9-G4) (HC359107)

Anti-Human CD47/MER6 Antibody (5F9-G4)
Anti-Human CD47/MER6 Antibody (5F9-G4)
Anti-Human CD47/MER6 Antibody (5F9-G4)
Anti-Human CD47/MER6 Antibody (5F9-G4)
Price(USD): $
Spec:
  • 50ug
  • 100ug
Number:
Contact us
  • Overview

  • Images

  • References

  • Datasheet

Overview
Catalog No.HC359107
Description
Anti-Human CD47/MER6 Antibody (5F9-G4) [5F9-G4] (HC359107) is a human monoclonal antibody detecting Protein MER6 in FCM. Suitable for Human.
Highlights
  • Flow Cytometry — Validated for flow cytometry applications.
Species reactivityHuman
ApplicationsFCM
Host speciesHuman
IsotypeIgG4, kappa
Clone ID5F9-G4
Clonality Monoclonal
Target Leukocyte surface antigen CD47, CD47, Antigenic surface determinant protein OA3, IAP, Integrin-associated protein, Protein MER6, MER6
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q08722
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Background

Leukocyte surface antigen CD47 (MER6) is a ~35 kDa protein. Adhesive protein that mediates cell-to-cell interactions. Acts as a receptor for thrombospondin THBS1 and as modulator of integrin signaling through the activation of heterotrimeric G proteins. Involved in signal transduction, cardiovascular homeostasis, inflammation, apoptosis, angiogenesis, cellular self-renewal, and immunoregulation. Plays a role in modulating pulmonary endothelin EDN1 signaling. Modulates nitrous oxide (NO) signaling, in response to THBS1, hence playing a role as a pressor agent, supporting blood pressure. CD47 is the therapeutic target of magrolimab (clinical).

1. Latour, S. et al. (2001) Journal of immunology (Baltimore, Md. : 1950) 167, 2547-54. PMID: 11509594
2. Piccio, L. et al. (2005) Blood 105, 2421-7. PMID: 15383453
3. Isenberg, JS. et al. (2009) The Journal of biological chemistry 284, 1116-25. PMID: 19004835
4. Lindberg, FP. et al. (1993) The Journal of cell biology 123, 485-96. PMID: 7691831
5. Gao, AG. et al. (1996) The Journal of biological chemistry 271, 21-4. PMID: 8550562
6. Rogers, NM. et al. (2017) Cardiovascular research 113, 15-29. PMID: 27742621
7. Ghimire, K. et al. (2020) Cells 9. PMID: 32679764
Note For research use only.
Images
  • Anti-Human CD47/MER6 Antibody (5F9-G4)

    Bioactivity

    SEC-HPLC detection for Anti-Human CD47/MER6 Antibody (5F9-G4).

  • Anti-Human CD47/MER6 Antibody (5F9-G4)

    Flow Cytometry

    Flow-cytometry using anti-human CD47 antibody. Jurkat cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human CD47 monoclonal antibody (Catalog HC359107, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (abinScience: HF690414) and cells analysed on a NovoCyte Flow Cytometer.

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list